231 related articles for article (PubMed ID: 7931827)
1. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms.
Baas IO; Mulder JW; Offerhaus GJ; Vogelstein B; Hamilton SR
J Pathol; 1994 Jan; 172(1):5-12. PubMed ID: 7931827
[TBL] [Abstract][Full Text] [Related]
2. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers.
Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G
J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356
[TBL] [Abstract][Full Text] [Related]
3. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ
Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 and 17p allelic loss in colorectal carcinoma.
Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B
Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158
[TBL] [Abstract][Full Text] [Related]
8. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms.
Baas IO; van den Berg FM; Mulder JW; Clement MJ; Slebos RJ; Hamilton SR; Offerhaus GJ
J Pathol; 1996 Mar; 178(3):264-7. PubMed ID: 8778330
[TBL] [Abstract][Full Text] [Related]
9. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection.
Lambkin HA; Mothersill CM; Kelehan P
J Pathol; 1994 Jan; 172(1):13-8. PubMed ID: 7931822
[TBL] [Abstract][Full Text] [Related]
10. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci.
Stopera SA; Bird RP
Cytobios; 1993; 73(293):73-88. PubMed ID: 8319499
[TBL] [Abstract][Full Text] [Related]
12. [Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma].
Hammel PR; Beuvon FX; Salmon RJ; Remvikos Y
Gastroenterol Clin Biol; 1991; 15(6-7):529-35. PubMed ID: 1916131
[TBL] [Abstract][Full Text] [Related]
13. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease.
Xerri L; Parc P; Bouabdallah R; Camerlo J; Hassoun J
J Pathol; 1995 Feb; 175(2):189-94. PubMed ID: 7738714
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
15. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications.
Pescarmona E; Pignoloni P; Santangelo C; Naso G; Realacci M; Cela O; Lavinia AM; Martelli M; Russo MA; Baroni CD
J Pathol; 1999 Aug; 188(4):400-6. PubMed ID: 10440751
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of mutant p53 oncogene in transitional mucosa adjacent to human colon cancer.
Baytner S; Mitmaker B; Gordon PH; Wang E
Clin Invest Med; 1993 Oct; 16(5):379-85. PubMed ID: 8261691
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval.
Piffko J; Bankfalvi A; Ofner D; Joos U; Böcker W; Schmid KW
J Pathol; 1995 May; 176(1):69-75. PubMed ID: 7616359
[TBL] [Abstract][Full Text] [Related]
19. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.
Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP
J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]